• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

三级医疗保健中心新冠肺炎患者的耳鼻喉科表现研究

A Study on Otorhinolaryngological Presentations in Covid 19 Patients in a Tertiary Health Care Center.

作者信息

Smitha S G, Pillai Nikitha, Nayak Bindya, Raveendran Jedhin

机构信息

Department of ENT, Kims Hospital, Bangalore, Karnataka India.

出版信息

Indian J Otolaryngol Head Neck Surg. 2022 Oct;74(Suppl 2):2935-2940. doi: 10.1007/s12070-021-02564-2. Epub 2021 Apr 27.

DOI:10.1007/s12070-021-02564-2
PMID:33937008
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8076440/
Abstract

Corona virus also known as 2019 novel corona virus, a single stranded positive sense RNA virus is the causative agent of COVID 19 disease. It mainly spreads via the respiratory route by means of aerosols. The objectives of our study were. To know the prevalence of ENT presentations in COVID 19 patients and to know the relationship between the symptoms and category of the disease as well as to know the relation between the blood group and recovery from the disease. The first 500 patients who were tested positive for COVID 19 and getting treated in our hospital were included in the study after taking written informed consent from the patients who were willing to participate in the study. A detailed history was taken from all the patients and more stress was given on the ENT symptoms with respect to its onset, duration and time taken for the relief of symptoms. The ENT symptoms were compared with the category of the disease as well as the blood group of the patients. Statistical analysis was done using Chi square test and Statistical Package for Social Sciences [SPSS] for Windows Version 22.0 Released 2013. Armonk, NY: IBM Corp., was used to perform statistical analyses. In our study 310 (62.0%) were males and 190 (38.0%) patients were females (38%), of age group ranging from 2 years to 87 years. In our study 367 (73.3%) patients were symptomatic and the rest 133 (26.6%) were asymptomatic. There were 335 (67.0%) patients in category A, 140 (28.0%) in category B and 25 (5.0%) in category C. The most common ENT presentation was headache and its prevelance was more in category C and it was of statistical significance. On comparing the blood group and the ENT symptoms occurrence of sore throat was of statistical significance and its prevelance was more among the O blood group patients. In terms of recovery from the disease the patients with blood group O had good recovery rate. Covid 19 pandemic is still an on going problem and newer strains of the virus are arising as well hence. In our study we found out that isolated ENT symptoms such as aguesia and anosmia were the only presentation of the disease. Thus they can be considered as early marker of the disease and it will be helpful in early detection and isolation of the patient as well as prevention of further spread of the disease.

摘要

冠状病毒也被称为2019新型冠状病毒,是一种单链正链RNA病毒,是新冠肺炎疾病的病原体。它主要通过气溶胶经呼吸道传播。我们研究的目的是:了解新冠肺炎患者耳鼻喉科症状的患病率,了解症状与疾病类别之间的关系,以及了解血型与疾病康复之间的关系。在获得愿意参与研究的患者的书面知情同意后,我们纳入了在我院接受治疗的首批500例新冠肺炎检测呈阳性的患者。我们收集了所有患者的详细病史,并特别关注耳鼻喉科症状的发作、持续时间以及症状缓解所需的时间。将耳鼻喉科症状与疾病类别以及患者的血型进行了比较。使用卡方检验和社会科学统计软件包[SPSS]Windows版本22.0(2013年发布,纽约州阿蒙克:IBM公司)进行统计分析。在我们的研究中,310名(62.0%)为男性,190名(38.0%)为女性,年龄范围从2岁到87岁。在我们的研究中,367名(73.3%)患者有症状,其余133名(26.6%)无症状。A类患者有335名(67.0%),B类患者有140名(28.0%),C类患者有25名(5.0%)。最常见的耳鼻喉科症状是头痛,其患病率在C类中更高,具有统计学意义。在比较血型与耳鼻喉科症状时,喉咙痛的发生率具有统计学意义,且在O型血患者中患病率更高。就疾病康复而言,O型血患者的康复率良好。新冠疫情仍然是一个持续存在的问题,并且新的病毒株也在不断出现。在我们的研究中,我们发现诸如味觉丧失和嗅觉丧失等孤立的耳鼻喉科症状是该疾病的唯一表现。因此,它们可被视为该疾病的早期标志物,这将有助于早期发现和隔离患者以及预防疾病的进一步传播。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84c7/9702367/36969c7b0ecd/12070_2021_2564_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84c7/9702367/533cd609e8c8/12070_2021_2564_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84c7/9702367/88951a363e09/12070_2021_2564_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84c7/9702367/36969c7b0ecd/12070_2021_2564_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84c7/9702367/533cd609e8c8/12070_2021_2564_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84c7/9702367/88951a363e09/12070_2021_2564_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84c7/9702367/36969c7b0ecd/12070_2021_2564_Fig3_HTML.jpg

相似文献

1
A Study on Otorhinolaryngological Presentations in Covid 19 Patients in a Tertiary Health Care Center.三级医疗保健中心新冠肺炎患者的耳鼻喉科表现研究
Indian J Otolaryngol Head Neck Surg. 2022 Oct;74(Suppl 2):2935-2940. doi: 10.1007/s12070-021-02564-2. Epub 2021 Apr 27.
2
Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.用于评估非住院轻中度 COVID-19 患者肠道微生物组调节的自然史和影响的虚拟化临床研究:一项随机、开放标签、前瞻性研究,平行组研究评估 KB109 对肠道微生物组结构和功能的生理影响:一项随机对照研究方案的结构化总结。
Trials. 2021 Apr 2;22(1):245. doi: 10.1186/s13063-021-05157-0.
3
Otorhinolaryngological Manifestations and Its Management in COVID 19 Patients.COVID-19患者的耳鼻喉科表现及其管理
Indian J Otolaryngol Head Neck Surg. 2022 Oct;74(Suppl 2):3391-3394. doi: 10.1007/s12070-021-02436-9. Epub 2021 Feb 17.
4
ENT Symptomology in Active COVID-19 Patients in our Tertiary Care Centre.我们三级医疗中心中新冠病毒肺炎确诊患者的耳鼻喉症状学
Indian J Otolaryngol Head Neck Surg. 2022 Oct;74(Suppl 2):3092-3097. doi: 10.1007/s12070-021-02815-2. Epub 2021 Aug 18.
5
Prevalence of Otorhinolaryngological Symptoms in Covid 19 Patients.新冠病毒肺炎患者耳鼻咽喉科症状的患病率
Indian J Otolaryngol Head Neck Surg. 2022 Oct;74(Suppl 2):3378-3384. doi: 10.1007/s12070-021-02410-5. Epub 2021 Feb 8.
6
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.COVID-19 住院成人患者使用伊马替尼的安全性和疗效:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Oct 28;21(1):897. doi: 10.1186/s13063-020-04819-9.
7
Safety and efficacy of antiviral combination therapy in symptomatic patients of Covid-19 infection - a randomised controlled trial (SEV-COVID Trial): A structured summary of a study protocol for a randomized controlled trial.抗病毒联合治疗在新冠病毒感染有症状患者中的安全性和有效性 - 一项随机对照试验(SEV-COVID 试验):一项随机对照试验研究方案的结构化总结。
Trials. 2020 Oct 20;21(1):866. doi: 10.1186/s13063-020-04774-5.
8
Clinical Spectrum of COVID-19 Cases and their Correlation with S.LDH Levels- An Observational Study from Southeast Rajasthan.COVID-19 病例的临床谱及其与 S.LDH 水平的相关性-来自拉贾斯坦邦东南部的观察性研究。
J Assoc Physicians India. 2021 Sep;69(9):11-12.
9
The Role of Otorhinolaryngological Manifestations of Mild Covid-19 Disease in Hilly Terrain: Lessons Learnt at a Secondary Care Hospital.轻度新冠病毒疾病的耳鼻喉科表现在山区的作用:一家二级护理医院的经验教训
Indian J Otolaryngol Head Neck Surg. 2022 Oct;74(Suppl 2):3337-3343. doi: 10.1007/s12070-022-03174-2. Epub 2022 Oct 15.
10
In COVID-19 Patients, the Identified Gastrointestinal Symptoms in Tertiary Care Center of India.在印度三级医疗中心的新冠肺炎患者中发现的胃肠道症状
Euroasian J Hepatogastroenterol. 2022 Jan-Jun;12(1):24-30. doi: 10.5005/jp-journals-10018-1371.

引用本文的文献

1
Study of Otorhinolaryngological Manifestations in Symptomatic COVID-19-Positive Patients at Tertiary Health Care Hospital: A Cross-sectional Study.三级医疗保健医院中症状性新冠病毒检测呈阳性患者的耳鼻喉科表现研究:一项横断面研究。
Int Arch Otorhinolaryngol. 2024 Jul 5;28(4):e597-e602. doi: 10.1055/s-0044-1786831. eCollection 2024 Oct.
2
The D614G Virus Mutation Enhances Anosmia in COVID-19 Patients: Evidence from a Systematic Review and Meta-analysis of Studies from South Asia.D614G 病毒突变增强了 COVID-19 患者的嗅觉丧失:来自南亚研究的系统评价和荟萃分析证据。
ACS Chem Neurosci. 2021 Oct 6;12(19):3535-3549. doi: 10.1021/acschemneuro.1c00542. Epub 2021 Sep 17.

本文引用的文献

1
Relationship between blood group and risk of infection and death in COVID-19: a live meta-analysis.新冠病毒肺炎中血型与感染及死亡风险的关系:一项实时荟萃分析。
New Microbes New Infect. 2020 Sep;37:100743. doi: 10.1016/j.nmni.2020.100743. Epub 2020 Aug 11.
2
Ear nose throat-related symptoms with a focus on loss of smell and/or taste in COVID-19 patients.新冠病毒感染者的耳鼻喉相关症状,重点是嗅觉和/或味觉丧失。
Am J Otolaryngol. 2020 Nov-Dec;41(6):102622. doi: 10.1016/j.amjoto.2020.102622. Epub 2020 Jun 23.
3
ENT manifestation in COVID-19 patients.
COVID-19患者的耳鼻喉科表现。
Auris Nasus Larynx. 2020 Aug;47(4):559-564. doi: 10.1016/j.anl.2020.06.003. Epub 2020 Jun 15.
4
Properties of Coronavirus and SARS-CoV-2.冠状病毒及新型冠状病毒(SARS-CoV-2)的特性
Malays J Pathol. 2020 Apr;42(1):3-11.
5
Clinical Presentation of COVID-19: A Systematic Review Focusing on Upper Airway Symptoms.新型冠状病毒肺炎的临床表现:以上呼吸道症状为重点的系统评价
Ear Nose Throat J. 2020 Nov;99(9):569-576. doi: 10.1177/0145561320920762. Epub 2020 Apr 13.
6
Hearing loss and COVID-19: A note.听力损失与2019冠状病毒病:一则笔记
Am J Otolaryngol. 2020 May-Jun;41(3):102473. doi: 10.1016/j.amjoto.2020.102473. Epub 2020 Apr 2.
7
Isolated sudden onset anosmia in COVID-19 infection. A novel syndrome?COVID-19 感染中的孤立性突发性嗅觉丧失。一种新综合征?
Rhinology. 2020 Jun 1;58(3):299-301. doi: 10.4193/Rhin20.114.
8
High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa.2019-nCoV 对口腔黏膜上皮细胞 ACE2 受体的高表达。
Int J Oral Sci. 2020 Feb 24;12(1):8. doi: 10.1038/s41368-020-0074-x.
9
The olfactory nerve: a shortcut for influenza and other viral diseases into the central nervous system.嗅神经:流感和其他病毒进入中枢神经系统的捷径。
J Pathol. 2015 Jan;235(2):277-87. doi: 10.1002/path.4461.
10
Human susceptibility and resistance to Norwalk virus infection.人类对诺如病毒感染的易感性和抵抗力。
Nat Med. 2003 May;9(5):548-53. doi: 10.1038/nm860. Epub 2003 Apr 14.